163 related articles for article (PubMed ID: 36877372)
1. oFlowSeq: a quantitative approach to identify protein coding mutations affecting cell type enrichment using mosaic CRISPR-Cas9 edited cerebral organoids.
Dawes P; Murray LF; Olson MN; Barton NJ; Smullen M; Suresh M; Yan G; Zhang Y; Fernandez-Fontaine A; English J; Uddin M; Pak C; Church GM; Chan Y; Lim ET
Hum Genet; 2023 Aug; 142(8):1281-1291. PubMed ID: 36877372
[TBL] [Abstract][Full Text] [Related]
2. FACS-Based Sequencing Approach to Evaluate Cell Type to Genotype Associations Using Cerebral Organoids.
Murray L; Olson MN; Barton N; Dawes P; Chan Y; Lim ET
Methods Mol Biol; 2023; 2683():193-199. PubMed ID: 37300776
[TBL] [Abstract][Full Text] [Related]
3. Mosaicism in CRISPR/Cas9-mediated genome editing.
Mehravar M; Shirazi A; Nazari M; Banan M
Dev Biol; 2019 Jan; 445(2):156-162. PubMed ID: 30359560
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9-Edited Site Sequencing (CRES-Seq): An Efficient and High-Throughput Method for the Selection of CRISPR-Cas9-Edited Clones.
Veeranagouda Y; Debono-Lagneaux D; Fournet H; Thill G; Didier M
Curr Protoc Mol Biol; 2018 Jan; 121():31.14.1-31.14.11. PubMed ID: 29337372
[TBL] [Abstract][Full Text] [Related]
5. Single-cell brain organoid screening identifies developmental defects in autism.
Li C; Fleck JS; Martins-Costa C; Burkard TR; Themann J; Stuempflen M; Peer AM; Vertesy Á; Littleboy JB; Esk C; Elling U; Kasprian G; Corsini NS; Treutlein B; Knoblich JA
Nature; 2023 Sep; 621(7978):373-380. PubMed ID: 37704762
[TBL] [Abstract][Full Text] [Related]
6. Improved CRISPR/Cas9 gene editing by fluorescence activated cell sorting of green fluorescence protein tagged protoplasts.
Petersen BL; Möller SR; Mravec J; Jørgensen B; Christensen M; Liu Y; Wandall HH; Bennett EP; Yang Z
BMC Biotechnol; 2019 Jun; 19(1):36. PubMed ID: 31208390
[TBL] [Abstract][Full Text] [Related]
7. Utilizing CRISPR/Cas9 technology to prepare lymphoblastoid cell lines harboring genetic mutations for generating quality control materials in genetic testing.
Zhou L; Li R; Zhang R; Peng R; Chen K; Gao P; Zhang J; Zhang R; Li J
J Clin Lab Anal; 2020 Jul; 34(7):e23256. PubMed ID: 32118319
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.
Kizner V; Naujock M; Fischer S; Jäger S; Reich S; Schlotthauer I; Zuckschwerdt K; Geiger T; Hildebrandt T; Lawless N; Macartney T; Dorner-Ciossek C; Gillardon F
Mol Neurobiol; 2020 Feb; 57(2):616-634. PubMed ID: 31402430
[TBL] [Abstract][Full Text] [Related]
9. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.
Liu X; Cheng Y; Abraham JM; Wang Z; Wang Z; Ke X; Yan R; Shin EJ; Ngamruengphong S; Khashab MA; Zhang G; McNamara G; Ewald AJ; Lin D; Liu Z; Meltzer SJ
Cancer Lett; 2018 Nov; 436():109-118. PubMed ID: 30144514
[TBL] [Abstract][Full Text] [Related]
10. Generation and immunofluorescent validation of gene knockouts in adult human colonic organoids using multi-guide RNA CRISPR-Cas9.
Chan DKH; Collins SD; Buczacki SJA
STAR Protoc; 2023 Mar; 4(1):101978. PubMed ID: 36598849
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones.
Smith RH; Chen YC; Seifuddin F; Hupalo D; Alba C; Reger R; Tian X; Araki D; Dalgard CL; Childs RW; Pirooznia M; Larochelle A
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33322084
[TBL] [Abstract][Full Text] [Related]
12. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
13. Gene-Edited Fluorescent and Mixed Cerebral Organoids.
Bachmann L; Gallego Villarejo L; Heinen N; Marks D; Peters M; Müller T
CRISPR J; 2022 Feb; 5(1):53-65. PubMed ID: 35099270
[TBL] [Abstract][Full Text] [Related]
14. Rapid generation of genetic diversity by multiplex CRISPR/Cas9 genome editing in rice.
Shen L; Hua Y; Fu Y; Li J; Liu Q; Jiao X; Xin G; Wang J; Wang X; Yan C; Wang K
Sci China Life Sci; 2017 May; 60(5):506-515. PubMed ID: 28349304
[TBL] [Abstract][Full Text] [Related]
15. Long-read individual-molecule sequencing reveals CRISPR-induced genetic heterogeneity in human ESCs.
Bi C; Wang L; Yuan B; Zhou X; Li Y; Wang S; Pang Y; Gao X; Huang Y; Li M
Genome Biol; 2020 Aug; 21(1):213. PubMed ID: 32831134
[TBL] [Abstract][Full Text] [Related]
16. TEAD4 regulates trophectoderm differentiation upstream of CDX2 in a GATA3-independent manner in the human preimplantation embryo.
Stamatiadis P; Cosemans G; Boel A; Menten B; De Sutter P; Stoop D; Chuva de Sousa Lopes SM; Lluis F; Coucke P; Heindryckx B
Hum Reprod; 2022 Jul; 37(8):1760-1773. PubMed ID: 35700449
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
18. Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9.
Yoder KE; Bundschuh R
Sci Rep; 2016 Jul; 6():29530. PubMed ID: 27404981
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
20. Genome Editing with CRISPR-Cas9: A Budding Biological Contrivance for Colorectal Carcinoma Research and its Perspective in Molecular Medicine.
Ray SK; Mukherjee S
Curr Mol Med; 2021; 21(6):462-475. PubMed ID: 33213345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
